Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Pfister

Showing results (31-40 of 161) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experienceSuzanne L Wolden, William C Chen, David G Pfister, et al.
Head & Neck|May 25, 2024
Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trialJames R Janopaul-Naylor, Lillian Boe, Yao Yu, et al.
Oral Oncology|March 26, 2022
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignanciesBharat Burman, Scott B Drutman, Matthew G Fury, et al.
JCO Clinical Cancer Informatics|August 26, 2021
ChemoPalRx-A Mobile App That Enhances Chemotherapy Prescription Accuracy: A Cross-Sectional StudyTony K W Hung, Serene Tareen, Sharvina Ziyeh, et al.
JAMA Oncology|October 9, 2015
Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer StageDavid G Pfister, David M Rubin, Elena B Elkin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trialRichard L Bakst, Nancy Lee, David G Pfister, et al.
Head & Neck|December 24, 2014
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabShrujal S Baxi, Caitriona O'Neill, Eric J Sherman, et al.
Head & Neck|October 1, 2017
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancerLara A Dunn, Matthew G Fury, Eric J Sherman, et al.
Advances in Radiation Oncology|December 9, 2022
Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck CancerDaniel Restifo, Gabriel Raab, Sean M McBride, et al.
Journal of Medical Internet Research|October 15, 2024
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical TrialsTony K W Hung, Gilad J Kuperman, Eric J Sherman, et al.
Pageof 17

Showing results (31-40 of 161) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experienceSuzanne L Wolden, William C Chen, David G Pfister, et al.
Head & Neck|May 25, 2024
Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trialJames R Janopaul-Naylor, Lillian Boe, Yao Yu, et al.
Oral Oncology|March 26, 2022
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignanciesBharat Burman, Scott B Drutman, Matthew G Fury, et al.
JCO Clinical Cancer Informatics|August 26, 2021
ChemoPalRx-A Mobile App That Enhances Chemotherapy Prescription Accuracy: A Cross-Sectional StudyTony K W Hung, Serene Tareen, Sharvina Ziyeh, et al.
JAMA Oncology|October 9, 2015
Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer StageDavid G Pfister, David M Rubin, Elena B Elkin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trialRichard L Bakst, Nancy Lee, David G Pfister, et al.
Head & Neck|December 24, 2014
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabShrujal S Baxi, Caitriona O'Neill, Eric J Sherman, et al.
Head & Neck|October 1, 2017
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancerLara A Dunn, Matthew G Fury, Eric J Sherman, et al.
Advances in Radiation Oncology|December 9, 2022
Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck CancerDaniel Restifo, Gabriel Raab, Sean M McBride, et al.
Journal of Medical Internet Research|October 15, 2024
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical TrialsTony K W Hung, Gilad J Kuperman, Eric J Sherman, et al.
Pageof 17